Non-coding RNA Profiling for Stem Cell Characterisation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing the quality, identity, and safety of stem cells and cell cultures are time-consuming, costly, and require skilled personnel, and do not effectively monitor phenotypic drift or safety profiles, particularly for clinical use.
Innovation Solution
Employing non-coding RNA expression profiling to characterize and monitor cell quality and safety by determining microRNA profiles, which can differentiate between phenotypically identical cells and identify potential alterations in cell physiology, including pluripotency and tumorigenicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If standard characterisation methods (surface antigens, enzymic activities, gene expression) are used to assess stem cell quality and identity, then cell characteristics can be evaluated, but the procedures are time-consuming, expensive, and require skilled staff
Solution Approach 1:
The invention extracts and focuses on a specific subset of microRNAs (particularly the miR-302 family and miR-520 family) that serve as critical markers for stem cell identity and pluripotency. By concentrating on these key molecular markers rather than进行全面 characterisation across multiple parameters, the method achieves accurate cell identification while significantly reducing assessment time and complexity
Solution Approach 2:
The invention shifts the characterisation parameter from traditional markers (surface antigens, enzymic activities) to microRNA expression profiles. This parameter change enables the use of sensitive molecular detection methods that can rapidly distinguish between pluripotent and differentiated states, providing faster and more informative assessment
2Reliability
If comprehensive characterisation methods are used to assess stem cell safety and phenotypic stability, then crucial safety information can be obtained, but the methods are complex and costly
Solution Approach 1:
The invention applies partial action by focusing on specific microRNA markers (miR-302 and miR-520 families) that are most indicative of stem cell safety and phenotypic stability. Rather than implementing comprehensive safety testing across all possible parameters, the method selectively monitors these critical markers to efficiently assess tumorigenicity risk and phenotypic drift
Solution Approach 2:
The invention uses microRNA expression profiles as an intermediary marker system that indirectly reflects complex cellular states including pluripotency, differentiation status, and tumorigenic potential. These microRNA markers serve as mediators that translate complex cellular phenotypes into measurable molecular signals, simplifying safety assessment
3Loss of information
If traditional QC assays are used to monitor cell quality and consistency, then basic cell characteristics can be assessed, but the methods do not reveal crucial safety profile information
Solution Approach 1:
The invention creates a multi-functional assessment tool where microRNA expression profiling simultaneously evaluates multiple critical aspects of stem cell quality including identity verification, pluripotency status, phenotypic stability, and safety profile. A single microRNA assay provides information that would otherwise require multiple separate tests, thereby increasing information content while maintaining efficiency
4Measurement precision
If phenotypic markers are used to identify cell populations, then cell identity can be determined, but phenotypically identical cells may have different safety profiles
Solution Approach 1:
The invention inverts the traditional approach by using molecular markers (microRNAs) to predict and assess phenotypic states and safety profiles, rather than relying solely on observed phenotypic characteristics. By measuring intracellular microRNA expression levels, the method can identify differences in cell state and safety risk before they manifest phenotypically, providing earlier and more reliable safety assessment
Data Source
AI summary
A method is provided that non-coding RNA profiles can be exploited as a means of monitoring, assessing, comparing, establishing and/or determining certain cell characteristics and/or profiles. Accordingly, the use of non-coding RNA molecules for characterising and/or profiling cells is provided.